Trastorno de estrés postraumático y riesgo de suicidio: definición y tratamiento
El trastorno de estrés postraumático (TEPT) es una enfermedad mental que puede desarrollarse en personas que han experimentado o presenciado un suceso traumático. Estos acontecimientos pueden incluir agresiones físicas o sexuales, desastres naturales, accidentes o cualquier situación que amenace la vida o el bienestar de una persona. Los síntomas incluyen uno intrusivo (recuerdos o sueños […]
DisruPep in South Summit 2023
DisruPep participated in the leading investment event in Europe – South Summit – last June 2023. Through the participation of the CataPull innovation program of the Madrid Science Park Foundation (FPCM), we shared a stand with FPCM and CSIC. Where we had the opportunity to present our biotech and our pipeline in the different therapeutic […]
How our PTSD drug candidate works: QBP1 peptide
Post-traumatic stress disorder occurs after a traumatic event through the formation of new proteins and neuronal connections, through the activation of a CPEB3 protein, which is involved in memory consolidation. This occurs mainly in the REM phase of sleep. QBP1 is a peptide that acts as a switch in CPB3 and memory consolidation. We have […]
DisruPep participated in 2 investment events, searching for specialized partners and investors.
Demo-day of the CSIC Dinamiza program In November 2022, DisruPep had the opportunity to participate in the demo-day of the CSIC Dinamiza program, at the CSIC headquarters in Madrid. The Dinamiza project is coordinated and managed by the Industrial Property and Entrepreneurship Support Area of the Deputy Vice Presidency of Knowledge Transfer (VATC) of the […]
Do you want to know more about us?
We leave you the video summary of participation in the CSIC Dinamiza program.
